Meyer; Colin J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Meyer; Colin J..The latest application filed is for "methods of treating alport syndrome using bardoxolone methyl or analogs thereof".

Company Profile

2.11.12

Meyer; Colin J. - Southlake TX
Meyer; Colin J. - Frisco TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of treating Alport syndrome using bardoxolone methyl or analogs thereof Grant 11,446,313 - Meyer September 20, 2	2022-09-20
Methods Of Treating Alport Syndrome Using Bardoxolone Methyl Or Analogs Thereof App 20210161914 - MEYER; Colin J.	2021-06-03
Methods of treating Alport syndrome using bardoxolone methyl or analogs thereof Grant 10,953,020 - Meyer March 23, 2	2021-03-23
Methods Of Treating Alport Syndrome Using Bardoxolone Methyl Or Analogs Thereof App 20190350941 - MEYER; Colin J.	2019-11-21
Methods Of Treating And Preventing Endothelial Dysfunction Using Bardoxolone Methyl Or Analogs Thereof App 20190091194 - CHIN; Melanie Pei-Heng ; et al.	2019-03-28
Methods Of Treating Obesity Using Antioxidant Inflammation Modulators App 20190076443 - MEYER; Colin J. ; et al.	2019-03-14
Methods of treating obesity using antioxidant inflammation modulators Grant 10,105,372 - Meyer , et al. October 23, 2	2018-10-23
Synthetic Triterpenoids And Methods Of Use In The Treatment Of Disease App 20180161311 - SPORN; Michael B. ; et al.	2018-06-14
Synthetic triterpenoids and methods of use in the treatment of disease Grant 9,757,359 - Sporn , et al. September 12, 2	2017-09-12
Delayed release, oral dosage compositions that contain amorphous CDDO-Me Grant 9,155,721 - Zhang , et al. October 13, 2	2015-10-13
Methods Of Treating And Preventing Endothelial Dysfunction Using Bardoxolone Methyl Or Analogs Thereof App 20150080465 - CHIN; Melanie Pei-Heng ; et al.	2015-03-19
Delayed Release, Oral Dosage Compositions That Contain Amorphous Cddo-me App 20140235711 - Zhang; Jiang ; et al.	2014-08-21
Delayed release, oral dosage compositions that contain amorphous CDDO-Me Grant 8,747,901 - Zhang , et al. June 10, 2	2014-06-10
Synthetic Triterpenoids And Methods Of Use In The Treatment Of Disease App 20130345276 - SPORN; Michael B. ; et al.	2013-12-26
Synthetic triterpenoids and methods of use in the treatment of disease Grant 8,455,544 - Sporn , et al. June 4, 2	2013-06-04
Synthetic Triterpenoids and Methods of Use in the Treatment of Disease App 20120220652 - Sporn; Michael B. ; et al.	2012-08-30
Synthetic triterpenoids and methods of use in the treatment of disease Grant 8,129,429 - Sporn , et al. March 6, 2	2012-03-06
Delayed Release, Oral Dosage Compositions That Contain Amorphous Cddo-me App 20120022156 - Zhang; Jiang ; et al.	2012-01-26
Methods Of Treating Obesity Using Antioxidant Inflammation Modulators App 20110281955 - Meyer; Colin J. ; et al.	2011-11-17
Synthetic Triterpenoids And Methods Of Use In The Treatment Of Disease App 20090326063 - Sporn; Michael B. ; et al.	2009-12-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.